- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Dietary management of conditions requiring a source of medium chain triglycerides, hyperlipoproteinaemia type 1, long chain fatty acid oxidation disorders, chlyous ascites and chylothorax
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 758KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 42KB)
Triglycerides medium chain formula – July 2020
Triglycerides medium chain formula: Oral powder 400 g; Monogen®
Last updated
30 October 2020